Despite the burden, migraine is not consistently recognized in health policy. However, countries are making progress and establishing a way forward for patients.In the latest Brain Talks episode, Sam Pauly sat down with Dawn Carlson, AbbVie's Vice-President of Neuroscience Clinical Development, and Alessandra Sorrentino, migraine patient and representative of Alleanza Cefalalgici, to discuss promising developments in migraine care, management, and policy prioritization.This episode was recorded in partnership with AbbVie.